title: The fourth China Bioanalysis Forum Annual Meeting.
abstract: The fourth China Bioanalysis Forum annual conference, co-organized with the Nanjing International Drug Metabolism Conference, was successfully held in Nanjing, China, between 24-26 June 2016. The theme of the conference was 'how to conduct regulated bioanalysis under China Food and Drug Administration (CFDA) regulations'. In addition, several hot topics including bioanalytical challenges, solutions for biomarkers, antidrug antibody (antibody-drug conjugates) and biologics were discussed. This Conference Report summarizes the major discussion topics from the conference.
authors.affiliation: United-Power PharmaTech, Beijing, China.
authors.forename: Daniel
authors.initials: D
authors.lastname: Tang
authors.affiliation: Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Pudong Xinqu, Shanghai Shi, China.
authors.forename: Dafang
authors.initials: D
authors.lastname: Zhong
authors.affiliation: GlaxoSmithKline R&D, Pudong, Shanghai, China.
authors.forename: Kelly
authors.initials: K
authors.lastname: Dong
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D002681:China; D002851:Chromatography, High Pressure Liquid; D006077:Government Agencies; D006801:Humans; D007118:Immunoassay; D018796:Immunoconjugates / Q000032:analysis / Q000493:pharmacokinetics; D013058:Mass Spectrometry
chemical_list: D015415:Biomarkers; D018796:Immunoconjugates
keywords: CBF; China Bioanalysis Forum; bioanalysis conference